Overall rank by patents
#24,321
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
The verdict
According to USPTO PatentsView, Family ranks #24,321 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R24321 · Foreign Corporation #24,321 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Exinda Networks PTY, Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Family Inada · this assignee
28 score
3D Lighting Innovati… · lowest
7 score
What this shows Family's Innovation Score is 28.1/100 (top 74% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Family Inada Co., Ltd. is a focused PatentsView assignee: 2 CPC subclasses with 72.7% of grants classified under A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2017. By volume, Family sits between Exinda Networks PTY, Ltd. and Finsecur.
Family Inada Co., Ltd. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Exinda Networks PTY, Ltd.
11 patents
ExlService Holdings, Inc.
11 patents
Ezaki Glico Co. Ltd.
11 patents
F-star Therapeutics Limited
11 patents
FIBERHOME TELECOMMUNICATION TECHNOLOGIES CO., LTD
11 patents
FIBERTEX PERSONAL CARE A/S
11 patents
FINIS INC.
11 patents
FINSECUR
11 patents
FAMILY INADA CO., LTD.
11 patents
What this shows Family holds 11 patents at rank #24,310, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,310 in granted patent volume.
Other assignees with the most granted patents in Family's primary technology class.
Family's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 Top 74% higher than 26% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2017 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
| 2023 | 2 | 18.2% |
| 2024 | 2 | 18.2% |
Top 2 of 2 technology areas
Overall rank by patents
#24,321
of 50,000 tracked assignees
28.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.